Interpace Diagnostics Group Inc. will implement a 1-for-10 reverse stock split of its outstanding common stock, effective for trading as of Dec. 29.

The stock split is intended to raise the per-share trading price of Interpace's common stock to satisfy the $1 minimum bid price requirement for continued listing on The Nasdaq Capital Market.

The split reduces the number of the company's common shares outstanding to about 2 million shares from about 20.2 million shares.

Interpace's common stock will continue trading on the NASDAQ Capital Market, on a post-split basis, under the existing trading symbol IDXG.